21.03.2012 Russian Venture Company’s Igor Agamirzian to Participate in 2012 Global Technology Symposium
28.02.2012 NeuroMax Announces IND Submission for Novel NM-IA-001 for The Treatment of Diabetic Neuropathy
24.02.2012 Quintiles and Russian Venture Company Biofund to expand clinical development capabilities in Russia